Lithium borohydride → N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[(1R)-2-hydroxy-1-methylethoxy]-4-pyrimidinyl]-cyclopropanesulfonamide
Reaction equation
[CH2:1]([O:3][C:4](=O)[C@H:5]([O:7][C:8]1[CH:13]=[C:12]([NH:14][S:15]([CH:18]2[CH2:20][CH2:19]2)(=[O:17])=[O:16])[N:11]=[C:10]([S:21][CH2:22][C:23]2[CH:28]=[CH:27][CH:26]=[C:25]([F:29])[C:24]=2[F:30])[N:9]=1)[CH3:6])[CH3:2].[BH4-].[Li+]>C1COCC1>[CH3:2][CH2:1][O:3][CH2:4][CH3:5].[CH3:26][CH2:25][CH2:24][CH:23]([CH3:28])[CH3:22].[F:30][C:24]1[C:25]([F:29])=[CH:26][CH:27]=[CH:28][C:23]=1[CH2:22][S:21][C:10]1[N:11]=[C:12]([NH:14][S:15]([CH:18]2[CH2:19][CH2:20]2)(=[O:17])=[O:16])[CH:13]=[C:8]([O:7][C@H:5]([CH3:6])[CH2:4][OH:3])[N:9]=1Participants
5
Reactant 2
Product 2
Reagents, catalysts & solvents 1
Procedure
The title compound was prepared according to the procedure outlined in example 24 using 2-[[6-[(cyclopropylsulfonyl)amino]-2-[[(2,3-difluorophenyl)methyl]thio]-4-pyrimidinyl]oxy]-(2R)-propanoic acid ethyl ester, (the product of step i) (0.30 g), THF (8 mL) and 2 M lithium borohydride in THF (2 mL). Purification was by reverse phase HPLC (symmetry as the stationary phase and TFA/acetonitrile as the mobile phase). The resulting oil was triturated with methanol, toluene, DCM, then ether/iso-hexane to give the title compound as a white solid. Yield: 0.20 g
Workup
- customThe title compound was prepared
- customPurification
- customThe resulting oil was triturated with methanol, toluene, DCM
Sources & evidence
- ORD record
- ord-6e725defee8749a5b15c9d75d42f3574
- Source dataset
- uspto-grants-2012_09
- Patent number
- US08269002B2
Reaction notes
Loading…